Zobrazeno 1 - 1
of 1
pro vyhledávání: '"MESH: Glycogen Storage Disease Type III"'
Autor:
Federico Mingozzi, Patrice Vidal, Helena Costa Verdera, Bernard Gjata, Francesco Puzzo, Giuseppe Ronzitti, Laetitia van Wittenberghe, Giacomo P. Comi, Gilles Mithieux, Fanny Collaud, Sabrina Lucchiari, Pascal Laforêt, Edoardo Malfatti, Louisa Jauze, Monika Gjorgjieva, Fabienne Rajas, Marcelo Simon Sola, Solenne Marmier, Alban Vignaud, Serena Pagliarani, Severine Charles, Isabelle Richard, Pasqualina Colella
Publikováno v:
Molecular Therapy
Molecular Therapy, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Molecular Therapy, Nature Publishing Group, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Molecular Therapy, Cell Press, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Molecular Therapy, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Molecular Therapy, Nature Publishing Group, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Molecular Therapy, Cell Press, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
International audience; Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder caused by a deficiency of glycogen-debranching enzyme (GDE), which results in profound liver metabolism impairment and muscle weakness. To date, no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3d6db8c62020fa021bbd621512248f
https://hal.science/hal-02332988
https://hal.science/hal-02332988
